Can sparsentan/sparsentan cure kidney disease?
Sparsentan/Sparsentan is an innovative drug recently developed and is mainly used in the treatment of IgA nephropathy. IgA nephropathy is a common primary glomerular disease. Although sparsentane has been effective in controlling proteinuria associated with IgA nephropathy, it must be clearly understood that it does not achieve a complete cure for the disease. Since the causes of IgA nephropathy are very complex and are mostly closely related to immune system disorders and genetic factors, the current treatment focus of the medical community is mainly focused on delaying the progression of the disease and improving the patient's quality of life.
Through clinical trials, sparsentane has been proven to significantly reduce proteinuria levels and even help restore kidney function in some patients. This is mainly due to its unique dual mechanism of action: first, by precisely inhibiting angiotensin receptors, optimizing the blood flow of renal tubules and glomeruli; second, by regulating immune responses, reducing the inflammatory state of the kidneys. For this reason, sparsentane is seen as a promising treatment option, especially for patients who have failed to respond to traditional treatments.
However, sparsentine must be used strictly in accordance with the instructions of a professional doctor. Although many patients may experience relief from symptoms during treatment, such as a reduction in proteinuria or resolution of edema, this does not equate to the complete elimination of the root cause of the disease. Therefore, patients must continue to adhere to treatment and undergo regular reexaminations to monitor changes in condition and adjust treatment strategies in a timely manner. If the patient ignores this and stops taking the medication without permission, it may lead to a rapid deterioration of the condition and even permanent damage to kidney function.
At the same time, patients should also pay close attention to possible side effects while using sparsentane. Among them, hypotension is one of the most common side effects, especially in the early stages of treatment or during drug dose adjustment. In order to prevent the occurrence of hypotension, patients should maintain adequate fluid intake and always pay attention to the body's reaction, such as dizziness, fatigue and other uncomfortable symptoms. If you notice any abnormalities, you should contact your doctor immediately and adjust the treatment plan if necessary.
Reference materials:https://pubmed.ncbi.nlm.nih.gov/38362830/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)